Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Long-Term Follow-up Study of Patients Who Received Prior Caribou Cell Therapy

NCT05332054 is registered in ClinicalTrials.gov with Caribou Biosciences, Inc. as lead sponsor.

NCT NCT05332054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05332054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Long-Term Follow-up Study of Patients Who Received Prior Caribou Cell Therapy
Lead sponsor
Caribou Biosciences, Inc.
Phase
Observational
Overall status
Enrolling by invitation
Start date
March 16, 2022
Completion date
December 31, 2041
Enrollment
150 (estimated)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

b cell lymphoma, b-cell non-hodgkin's lymphoma, hematologic malignancy, lymphoma, lymphoma, non-hodgkin, non-hodgkin lymphoma, refractory b-cell non-hodgkin lymphoma, relapsed non-hodgkin lymphoma, relapsed/refractory acute myeloid leukemia, relapsed/refractory multiple myeloma